logo
  • About Initiator Pharma
    • Mission
    • Scientific and Clinical Advisory Board
    • Goals, strategy and business model
    • CEO Letter
    • History
  • Science
    • Pipeline
    • Pudafensine
      • Clinical programs
        • IPED2015 – Organic Erectile dysfunction
        • IPVU2025 – Neuropathic Pain/Vulvodynia
      • Preclinical program
        • IPFSD2023 – Female Sexual Dysfunction
    • IP2018
      • Clinical programs
        • IP2018 – Psychogenic Erectile dysfunction
      • Preclinical program
        • IPFSD2023 – Female Sexual Dysfunction
    • Therapeutic Areas
      • Erectile Dysfunction
      • Vulvodynia
      • Female Sexual Dysfunction
      • Depression
  • Governance
    • General Meetings
    • Management
    • Board of Directors
    • Auditing
    • Articles of Association
    • Remuneration and incentive program
  • Investors
    • Rights Issue 2025
    • Investment case
    • Financial Reports
    • The Share
    • Ownership Structure
    • Analyst and Media Coverage
    • Financial Calendar
    • Prospectuses
    • Press Releases
    • Subscribe
    • Certified Adviser
  • Media
    • Press Releases
    • Event Calendar
    • Subscribe
  • Contact
Loading..

Financial Calendar

Upcoming events
  • 2026
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • All years
All events
  • Event calendar
  • Financial calendar
November 3 - November 5, 2025 Vienna
Austria

BIO-EUROPE

Add to calendar
November 12 - November 13, 2025 Lund
Sweden

BioStock, The Summit

Add to calendar
November 21, 2025

Interim Report Q3 2025

Add to calendar
December 3, 2025

Redeye Life Science Day

Add to calendar
February 20, 2026

Year-end report Q4 2025

Add to calendar
  • Investors
    • Rights Issue 2025
    • Investment case
    • Financial Reports
    • The Share
    • Ownership Structure
    • Analyst and Media Coverage
    • Financial Calendar
    • Prospectuses
    • Press Releases
    • Subscribe
    • Certified Adviser

Share

Read more
Initiator Pharma logo
About Initiator Pharma
  • Mission
  • Scientific and Clinical Advisory Board
  • Goals, strategy and business model
  • CEO Letter
  • History
Science
  • Pipeline
  • Pudafensine
    • Clinical programs
    • Preclinical program
  • IP2018
    • Clinical programs
    • Preclinical program
  • Therapeutic Areas
    • Erectile Dysfunction
    • Vulvodynia
    • Female Sexual Dysfunction
    • Depression
Governance
  • General Meetings
  • Management
  • Board of Directors
  • Auditing
  • Articles of Association
  • Remuneration and incentive program
Investors
  • Rights Issue 2025
  • Investment case
  • Financial Reports
  • The Share
  • Ownership Structure
  • Analyst and Media Coverage
  • Financial Calendar
  • Prospectuses
  • Press Releases
  • Subscribe
  • Certified Adviser
Media
  • Press Releases
  • Event Calendar
  • Subscribe
Contact

Share

Read more
  • Cookies
  • Privacy